Sign In
Buy RBGLY
$12.13
+0.0180 (+0.149%)
At Close: Jun 03, 2026
NEW YORK CITY, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Reckitt Benckiser Group plc ("Reckitt" or "the
The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Reckitt Benckiser Group plc For Securities Fraud
11:00am, Saturday, 01'st Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reckitt B
LOS ANGELES, CA / ACCESS Newswire / January 31, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reckitt B
The Schall Law Firm Urges Shareholders With Losses To Join An Investigation Into Reckitt Benckiser Group plc For Securities Fraud
08:00pm, Thursday, 30'th Jan 2025
LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reckitt B
RBGLY Investors Have Opportunity to Join Reckitt Benckiser Group plc Securities Fraud Investigation with the Schall Law Firm
02:58pm, Thursday, 30'th Jan 2025
LOS ANGELES--(BUSINESS WIRE)--RBGLY Investors Have Opportunity to Join Reckitt Benckiser Group plc Securities Fraud Investigation with the Schall Law Firm.
My New Year's Resolution For 2025: Invest $10,000 In These 6 Stocks
10:00am, Monday, 30'th Dec 2024
I review here the stocks of six quality companies that I am convinced will bring me closer to my ambitious goal of being able to fund my living expenses through dividends. Dividend growth investing is
Reckitt Benckiser: Still Cheap On Nutrition Woes
05:18pm, Monday, 23'rd Dec 2024
Reckitt Benckiser shareholders have had a tough year, with the stock underperforming global staples by around 17 points since my last article in January. Uncertainty surrounding the cost of litigation
Reckitt to lead charge in European consumer staples rebound, says HSBC
07:49am, Wednesday, 11'th Dec 2024
HSBC has raised its rating on Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) from ‘hold' to ‘buy' as part of a reassessment of European consumer staples stocks. Share prices across the entire Euro
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into Reckitt Benckiser Group PLC (OTC: RBGLY)
05:00pm, Thursday, 05'th Dec 2024
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Reckitt Benckiser Group PLC (“Reckitt”
Reckitt Benckiser adds tier-one execs to board
04:55am, Wednesday, 27'th Nov 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) bolstered its boardroom, adding more c-suite expertise in non-executive positions. Bacardi chief executive Mahesh Madhavan is taking a seat as a non-exec
Advent, Apollo among potential bidders for Reckitt's homecare assets, Bloomberg News reports
10:53am, Wednesday, 06'th Nov 2024
Private equity groups Advent International and Apollo Global are among firms mulling a potential buyout of British consumer goods company Reckitt's homecare assets, Bloomberg News reported on Wednesda
Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win
10:51am, Friday, 01'st Nov 2024
Shares of Abbott Laboratories (ABT) are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a jury cleared the two infant formula makers of liability for a boy's de
Reckitt Benckiser got 'best-case' outcome in latest US infant formula trial, broker suggest
08:26am, Friday, 01'st Nov 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) got the 'best case scenario' result in the Whitfield trial in Missouri, say analysts at Barclays, as all the infant formula NEC liability claims were d
Abbott Labs and Reckitt Benckiser shares surge on court's baby formula ruling
05:37am, Friday, 01'st Nov 2024
A court in St. Louis, Missouri ruled in favor of Abbott Laboratories and Reckitt Benckiser over claims their specialized baby formula caused users to develop a bowel disease called NEC
Reckitt Benckiser shares jump after clearance in latest baby formula trial
04:36am, Friday, 01'st Nov 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) shares climbed over 10% on Friday morning after the consumer group was cleared in the latest trial on disease risks related to baby formula. A court in
